Basic Information
Basic information for MIR9-3HG-212-79aa
Peptide Name MIR9-3HG-212-79aa
Genome Position chr15:89368097-89368235,89378042-89378139[+]
Species Human
Peptide Sequence MILTTSACERPPHRPPRPGPQEPEEPRGAQRRPSGLQLDGAAAPRPVTPLLVPPSLARFPPAIGALFAVTNSPAASSTD
Peptide Length 79
Unique No (MIR9-3HG-214-79aa,MIR9-3HG-218-79aa)
Grand Average of Hydropathicity -0.4266
Relative Molecular Mass 9645.67
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000654079;MIR9-3HG-212
Transcript Length 4019
Coding Ability 0.521
DNA Sequence Corresponding to Peptide ATGATTCTCACAACTTCTGCGTGCGAGCGCCCGCCCCACCGACCGCCCCGGCCCGGCCCGCAAGAGCCAGAGGAGCCGAGAGGAGCCCAGCGCCGGCCCAGCGGACTCCAGCTCGACGGAGCGGCCGCGCCCCGACCAGTTACTCCCCTGCTGGTGCCTCCCTCCTTGGCGCGCTTCCCACCTGCGATCGGCGCCCTCTTCGCAGTCACGAACTCGCCAGCAGCTAGCAGCACTGAC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :